Robinson Chandler
Chief Executive Officer · 12 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | MNPR | Monopar Therapeutics | Tax withholding | 4,084 | $92.59 | $378,137.56 | filing |
| 2026-06-30 | MNPR | Monopar Therapeutics | Option exercise | 12,873 | — | — | filing |
| 2026-03-31 | MNPR | Monopar Therapeutics | Tax withholding | 1,972 | $54.79 | $108,045.88 | filing |
| 2026-03-31 | MNPR | Monopar Therapeutics | Option exercise | 6,732 | — | — | filing |
| 2025-12-31 | MNPR | Monopar Therapeutics | Tax withholding | 2,558 | $65.30 | $167,037.40 | filing |
| 2025-12-31 | MNPR | Monopar Therapeutics | Option exercise | 8,724 | — | — | filing |
| 2025-09-30 | MNPR | Monopar Therapeutics | Tax withholding | 2,646 | $81.67 | $216,098.82 | filing |
| 2025-09-30 | MNPR | Monopar Therapeutics | Option exercise | 8,726 | — | — | filing |
| 2025-07-14 | MNPR | Monopar Therapeutics | Sale | 16,800 | $40.00 | $672,020.16 | filing |
| 2025-07-14 | MNPR | Monopar Therapeutics | X | 16,800 | $0.01 | $84.00 | filing |
| 2025-06-30 | MNPR | Monopar Therapeutics | Tax withholding | 5,865 | $35.78 | $209,849.70 | filing |
| 2025-06-30 | MNPR | Monopar Therapeutics | Option exercise | 13,344 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.